Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Global biopharma cold chain product sales 2016-2022

Global biopharma cold chain product sales from 2016 to 2022 (in billion U.S. dollars)

Global biopharma cold chain product sales 2016-2022 This statistic displays the predicted overall trend for biopharma cold chain product sales from 2016 to 2022. In 2018, it is expected that 318 billion U.S. dollars worth of biopharma cold-chain products will be sold globally. A general increase in cold-chain products is expected, likely due to the ongoing transition to bio-based products, rigorous preconditions of life science shipments linked with the growing globalization of the pharmaceutical trade. Cold-chain products require colder temperatures throughout the storage, handling, and transportation processes to maintain product integrity.
Show more

Global biopharma cold chain product sales from 2016 to 2022 (in billion U.S. dollars)

Sales in billion U.S. dollars
--
--
--
--
Sales in billion U.S. dollars
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Download Settings Share
Download started
Please be patient - this may take a moment
This statistic displays the predicted overall trend for biopharma cold chain product sales from 2016 to 2022. In 2018, it is expected that 318 billion U.S. dollars worth of biopharma cold-chain products will be sold globally. A general increase in cold-chain products is expected, likely due to the ongoing transition to bio-based products, rigorous preconditions of life science shipments linked with the growing globalization of the pharmaceutical trade. Cold-chain products require colder temperatures throughout the storage, handling, and transportation processes to maintain product integrity.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Cold chain logistics
Cold chain logistics

All Information
in one Presentation

Cold chain logistics

Everything On "Cold chain logistics" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Cold chain logistics"
  • Market overview
  • Food industry
  • Pharmaceutical industry
The most important statistics
  • U.S. cold chain logistics market
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.